The International Polycap Study 3 (TIPS-3)

PHASE3CompletedINTERVENTIONAL
Enrollment

7,793

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

June 30, 2020

Study Completion Date

August 30, 2021

Conditions
Cardiovascular DiseaseFracturesCancers
Interventions
DRUG

Polycap

Polycap (thiazide 25mg, atenolol 100mg, ramipril 10mg, simvastatin 40mg) taken once daily

DRUG

Aspirin

75 mg daily

DRUG

Vitamin D

60,000 IU monthly

DRUG

Matching Placebo

Matching Placebo

Trial Locations (9)

Unknown

Eminence, Dhaka

Fundaction Oftamologica De Santander (FOSCAL), Bucaramanga

St. John's Medical College Hospital, Bangalore

Harapan Kita Hopsital, Jakarta

Universiti Teknologi MARA (UiTM), Shah Alam

Adult Medicine & Medical Research Unit, Philippine General Hospital, Manila

Pamoja Tunaweza Women's Centre, Moshi

Fattouma Bourguiba University Hospital, Monastir

L8L 2X2

Hamilton Health Sciences, Hamilton

All Listed Sponsors
collaborator

Cadila Pharnmaceuticals

INDUSTRY

collaborator

Wellcome Trust

OTHER

collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

collaborator

Heart and Stroke Foundation of Ontario

OTHER

lead

Population Health Research Institute

OTHER